CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

BACKGROUND: Accumulating evidence suggests that the balance between pathogenic effector T cells (Teffs) and regulatory T cells (Tregs) may be important for controlling atherosclerotic disease. We hypothesized that a combination therapy with anti‐CD3 antibody (CD3‐Ab) and IL‐2/anti‐IL‐2 monoclonal an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kasahara, Kazuyuki, Sasaki, Naoto, Yamashita, Tomoya, Kita, Tomoyuki, Yodoi, Keiko, Sasaki, Yoshihiro, Takeda, Masafumi, Hirata, Ken‐ichi
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187475/
https://ncbi.nlm.nih.gov/pubmed/24755152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000719
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars